ロード中...
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
An estimated 50-90% of individuals with cocaine use disorder (CUD) also report using alcohol. Cocaine users report co-abusing alcohol to ‘self-medicate’ against the negative emotional side effects of the cocaine ‘crash’, including the onset of anxiety. Thus, pharmaceutical strategies to treat CUD wo...
保存先:
| 出版年: | Neuropharmacology |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7736532/ https://ncbi.nlm.nih.gov/pubmed/33091458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2020.108359 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|